Results for protein translation from Maltese to English

protein crops
thessaly

protein fl-awrina
back pain

≥ 6.2log2 tn tajter1 protein do
6.2 log2 tn titre protein do

pap protein ta’ l-annimali proċessat
pap processed animal protein

lamtu tal-qamħirrun soy protein fines
maize starch soy protein fines

albumina umana u plasma protein fraction umana
human albumin and human plasma protein fraction

formulae manifatturati mill-idrolizzati parzjali ta’ protein
formulae manufactured from protein partial hydrolysates

furosine: massimu 10 mg sa 100 g ta' protein.
furosine: maximum 10 mg to 100 g of protein.

protein pap (antivirali phytolacca americana) (inncn)
protein pap (phytolacca americana antiviral) (inncn)

kategorija farmakoterapewtika: aġenti antineoplastiċi, inibituri tal-protein kinase.
pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitors.

votrient huwa tip ta’ mediċina msejħa inibitur ta’ protein kinase.
votrient is a type of medicine called a protein kinase inhibitor.

dawn il- kompawnda jaġixxu billi jibblokaw tipi ta ’ enżimi magħrufa bħala protein kinases.
these compounds act by blocking types of enzymes known as protein kinases.

imsaren artifiċjali (qxur taz-zalzett) ta protein imwebbes jew materjali taċ-ċelluloża
artificial guts (sausage skins) of hardened protein or cellulosic materials

grupp farmakoterapewtiku: sustanzi antineoplastiċi, inibituri tal-protein kinase, kodiċi atc: l01xe17
pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitors, atc code: l01xe17

għall kull doża ta ’ 2 ml ≥ 5. 9log2 tn tajter1 protein do ≥ 4. 2 log2 aggl.
titre1 inactivated b. bronchiseptica cells

≥ 6.2log2 tn tajter1 protein do ( derivattiv mhux tossiku minn velenu dermo-nekrotiku ta’
6.2 log2 tn titre protein do (non-toxic deletion derivative of pasteurella multocida dermonecrotic toxin)

għalhekk, filtru in-line low protein binding ta’ 0.2 micron għandu jintuża għall- għoti.
therefore, a 0.2 micron low protein binding in-line filter should be used for administration.

kategorija farmakoterapewtika: aġenti anti-neoplastiċi, inibituri ta' protein kinase, kodiċi atc: l01xe35.
pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitors; atc code: l01xe35.

kategorija farmakoterapewtika: sustanzi antineoplastiċi, inibitur tal-protein-tyrosine kinase; kodiċi atc: l01xe16.
pharmacotherapeutic group: anti-neoplastic agents, protein kinase inhibitor; atc code: l01xe16.

bl- imblukkar tas- c5 complement protein, eculizumab 7 westferry circus, canary wharf, london, e14 4hb, uk tel.
7 westferry circus, canary wharf, london e14 4hb, uk tel.